Global Diabetes Drugs Market Analysis


  • Type: Common Disease Area
  • Published : March 2021
  • Region: Worldwide
  • Country: Other
  • Report ID : 322

  • Format: PPT, PDF

Global Diabetes Drugs Market – Size, Share, Impact, Growth, Trends, And Forecasts (2019 – 2028)


Report Overview

The global Diabetes market size stood at USD 69.7 billion 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

The significant growth in the market can be attributed to factors, such as the rising prevalence of diabetes and an increasing number of programs initiated by various health organizations related to health awareness. North America holds a major market share as of 2019, followed by the Asia-pacific region. The increase in the number of diabetes patients is mainly due to increasing obesity among people caused by unhealthy diets and sedentary lifestyles. Based on drugs, Insulin holds a significant share in the market

Market Growth Drivers

Rising awareness about preventive care and technological advancement are among the factors expected to boost market growth. According to the International Diabetes Federation, the global diabetes population is expected to reach 700 million by 2045 from 463 million in 2019. Technological advancement and frequent new product launches are the factors expected to have a propelling effect on the market during the forecast period.

Rising healthcare funding by government and private institutions in the field of diabetes care is contributing to constant improvement in novel diabetes management solutions.

1. Global Diabetes Drugs Market Overview……………………………………………………
A. Market Size
2. Market Growth Driver and Restraints……………………………………………………….
A. Rise in Global Prevalence of Diabetes Mellitus
B. Growing R&D Investments
C. Rising Cost of Drugs
D. Long Approval Time
3. Diabetes Market Segmentation………………………………………………………………………
A. Drug Class
I. Insulin
I. DPP-4 Inhibitors
II. GLP-1 Receptor Agonists
III. SGLT2 Inhibitors
IV. Others
B. Geography
I. North America Market Analysis
II. Europe Market Analysis
III. Asia-Pacific Market Analysis
IV. Middle East and Africa Market Analysis
C. Route of Administration
I. Oral
II. Intravenous
III. Subcutaneous
4. Diabetes Major Drugs Market Share………………………………………………………….
A. Market Analysis, Insights and Forecast – By Drug Type
5. Competitive Landscape……………………………………………………….………………………..
A. Major Players
B. Products in Pipeline
6. Key Company Profiles……………………………………………………………………………………
A. Novo Nordisk Company overview, Product & Services, Strategies & Financials
B. Sanofi Company overview, Product & Services, Strategies & Financials
C. AstraZeneca Company, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape……………………………………….
A. Policy changes and Reimbursement scenario
8. Factors Driving Future Growth……………………………………………………………………
A. New Trends and Development of Cardiovascular drug market
B. Future Opportunities
9. Potential Market Opportunities
A. Potential prospects in the market
10. Conclusion

Market Segmentation

By Drug Class:

The diabetes care drugs market is segmented by drugs into insulin (basal or long-acting, bolus or fast-acting, traditional human insulin drugs, and insulin biosimilars), oral anti-diabetic drugs (alpha-glucosidase inhibitors, DPP-4 inhibitors, and SGLT-2 inhibitors), non-insulin injectable drugs (GLP-1 receptor agonists, and Amylin Analogue), and combination drugs (combination insulin, oral combination). The insulin segment is expected to increase with a CAGR of over 2.5% during the forecast period, mainly due to the demand from the Type-1 diabetes population, which was more than 30 million by the end of 2019. Some of the Type-2 patients also depend on insulin. Although only 10% of the diabetes population is Type-1, the intake of insulin is higher in them.

By Route of administration:

Based on the route of administration, the global diabetes drug market can be segmented into oral, subcutaneous, and intravenous. The hypertension segment is anticipated to grow at a faster CAGR. This is primarily due to the increasing prevalence of diabetes and a large number of patients across the world.

By Region:

America dominates the global diabetes drug market owing to the large diabetic patient population. According to the WHO, in 2016, 9.6% of the total American population was suffering from diabetes. In addition to this, the increasing number of obese people, changing lifestyles, and increasing healthcare expenditure have boosted the growth of the diabetes drug market in America.

Europe accounts for the second-largest diabetes drug market, which is followed by Asia Pacific. The huge smoking population, availability of funds for research, and government support for research & development will drive the diabetes drug market in Europe.

Asia Pacific is the fastest-growing region for the diabetes drug market due to the presence of a huge patient population, continuously developing economies, and increasing need for better treatment.


On the other hand, the Middle East & Africa has the least share in the global diabetes drug market due to the presence of a poor economy, especially in the Africa region. Middle East holds the major share in the Middle East & Africa diabetes drug market owing to well-developed healthcare sector and huge healthcare expenditure.

Major Players

The diabetes drug market is moderately competitive and consists of several major players. Few of the key players are developing novel products and technologies to compete with the existing products while others are acquiring and partnering with the other companies trending in the market. Some of the companies which are currently dominating the market are C. H. Boehringer Sohn AG & Co KG, Amgen Inc, Baxter International Inc, Pfizer Inc, and Novartis AG. The major players in the global diabetes drug market are Eli Lilly (US), Novo Nordisk (Denmark), Abbott (US), AstraZeneca (UK), Biocon (US), Sun Pharma (India), Sanofi (France), Novartis (Switzerland), Merck & Co. (US), Pfizer (US), Daiichi Sankyo (Japan), Boehringer Ingelheim (Germany), Akros Pharma (US), Amgen (US), Adocia (France), Peptron (South Korea), Takeda (Japan).

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements